Recombinant EGFR (Nimotuzumab Biosimilar) anticorps
Aperçu rapide pour Recombinant EGFR (Nimotuzumab Biosimilar) anticorps (ABIN7072381)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- Anti-EGFR domain III [h-R3 (Nimotuzumab)], Human IgG1, kappa
-
Specificité
- Binds to human EGFR domain III at a site distinct from antibody 7A7 (Ab00134) (Talavera et al. 2011)
-
Attributs du produit
-
Original Species of Ab: Human
Original Format of Ab: IgG1
-
Purification
- Protein A affinity purified
-
Immunogène
- This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors.
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- This antibody binds to human EGFR and inhibits EGF-dependent clonogenic growth of NRK cells and completely blocks EGF stimulated autophosphorylation of the receptor (Fernandez 1992)
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- EGFR (Nimotuzumab Biosimilar)
-
Classe de substances
- Biosimilar
-
Sujet
- ERBB-D3, ERBB1, HER1, PIG61, mENA, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1, epidermal growth factor
-
UniProt
- P00533
Antigène
-